Literature DB >> 26603234

Toxoplasma-SPECIFIC IgG SUBCLASS ANTIBODY RESPONSE IN CEREBROSPINAL FLUID SAMPLES FROM PATIENTS WITH CEREBRAL TOXOPLASMOSIS.

Fernanda S Nascimento1, Lisandra A Suzuki1, Nilson Branco2, Regina M B Franco2, Paula D Andrade3, Sandra C B Costa3, Marcelo N Pedro3, Cláudio L Rossi1.   

Abstract

Cerebral toxoplasmosis can be highly debilitating and occasionally fatal in persons with immune system deficiencies. In this study, we evaluated the Toxoplasma gondii-specific IgG subclass antibody response in 19 cerebrospinal fluid (CSF) samples from patients with cerebral toxoplasmosis who had a positive IgG anti-T. gondii ELISA standardized with a cyst antigen preparation. There were no significant differences between the rates of positivity and the antibody concentrations (arithmetic means of the ELISA absorbances, MEA) for IgG1 and IgG2, but the rates of positivity and MEA values for these two IgG subclasses were significantly higher than those for IgG3 and IgG4. The marked IgG2 response in CSF from patients with cerebral toxoplasmosis merits further investigation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26603234      PMCID: PMC4660456          DOI: 10.1590/S0036-46652015000500013

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  25 in total

1.  Sequential determination of IgG subclasses and IgA specific antibodies in primary and reactivating toxoplasmosis.

Authors:  F Derouin; G Sulcebe; J J Ballet
Journal:  Biomed Pharmacother       Date:  1987       Impact factor: 6.529

2.  Intrathecal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the acquired immunodeficiency syndrome (AIDS).

Authors:  I Potasman; L Resnick; B J Luft; J S Remington
Journal:  Ann Intern Med       Date:  1988-01       Impact factor: 25.391

3.  Fractionation of membrane components from tachyzoite forms of Toxoplasma gondii: differential recognition by immunoglobulin M (IgM) and IgG present in sera from patients with acute or chronic toxoplasmosis.

Authors:  M Giraldo; H Cannizzaro; M A Ferguson; I C Almeida; R T Gazzinelli
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 4.  Toxoplasma gondii tachyzoite-bradyzoite interconversion.

Authors:  Russell E Lyons; Rima McLeod; Craig W Roberts
Journal:  Trends Parasitol       Date:  2002-05

Review 5.  Toxoplasma gondii: from animals to humans.

Authors:  A M Tenter; A R Heckeroth; L M Weiss
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

Review 6.  Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis.

Authors:  Jose G Montoya
Journal:  J Infect Dis       Date:  2002-02-15       Impact factor: 5.226

Review 7.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

Review 8.  Developmentally regulated biosynthesis of carbohydrate and storage polysaccharide during differentiation and tissue cyst formation in Toxoplasma gondii.

Authors:  Alexandra Coppin; Florence Dzierszinski; Sandra Legrand; Marlène Mortuaire; David Ferguson; Stanislas Tomavo
Journal:  Biochimie       Date:  2003 Mar-Apr       Impact factor: 4.079

9.  IgG2 subclass restriction of antibody to pneumococcal polysaccharides.

Authors:  D J Barrett; E M Ayoub
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

10.  Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis.

Authors:  J K Frenkel; A Escajadillo
Journal:  Am J Trop Med Hyg       Date:  1987-05       Impact factor: 2.345

View more
  3 in total

1.  Comparative Performance of Recombinant GRA6, GRA7, and GRA14 for the Serodetection of T. gondii Infection and Analysis of IgG Subclasses in Human Sera from the Philippines.

Authors:  Rochelle Haidee Ybañez; Yoshifumi Nishikawa
Journal:  Pathogens       Date:  2022-02-21

2.  Assessing antibody decline after chemotherapy of early chronic Chagas disease patients.

Authors:  Niamh Murphy; M Victoria Cardinal; Tapan Bhattacharyya; Gustavo F Enriquez; Natalia P Macchiaverna; Alejandra Alvedro; Héctor Freilij; Pablo Martinez de Salazar; Israel Molina; Pascal Mertens; Quentin Gilleman; Ricardo E Gürtler; Michael A Miles
Journal:  Parasit Vectors       Date:  2021-10-20       Impact factor: 3.876

3.  Association of gestational diabetes mellitus and negative modulation of the specific humoral and cellular immune response against Toxoplasma gondii.

Authors:  Ana Carolina de Morais Oliveira-Scussel; Paula Tatiana Mutão Ferreira; Renata de Souza Resende; Cristhianne Molinero Ratkevicius-Andrade; Angelica de Oliveira Gomes; Marina Carvalho Paschoini; Fernanda Bernadelli De Vito; Thaís Soares Farnesi-de-Assunção; Marcos Vinícius da Silva; José Roberto Mineo; Denise Bertulucci Rocha Rodrigues; Virmondes Rodrigues
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.